Skip to main content

Icariin Enhances Radiosensitivity of Colorectal Cancer Cells by Suppressing NF-κB Activity

Abstract

Radiation therapy is an integral part of the current therapeutic protocols in colorectal cancer. However, only a small proportion of the patients achieved complete pathological response because of the treatment-induced resistance to radiation. Previous studies have shown that radioresistance is associated with NF-κB activation and that suppression of NF-κB could potentiate the response of colorectal cancer cells to radiotherapy. Icariin, a natural flavonoid, has been shown to suppress NF-κB activity. The present study was carried out to investigate whether icariin could act as a radiosensitizer in colorectal cancer cells and murine model of the colorectal cancer. We also sought to understand the mechanisms underlying the icariin-mediated radiosensitization. Our results showed that icariin enhanced the radiation-mediated anti-proliferative effect both in vitro and in vivo. Further, icariin exerted the anti-proliferative and/or pro-apoptotic effect possibly, by: (1) inducing the cell arrest in G2/M phases of the cell cycle, or by (2) downregulating NF-κB and the anti-apoptotic gene products monitored by this transcription factor. Icariin could also potentiate the efficacy of radiotherapy in the murine model of colorectal cancer. Taken together, these results suggest that the use of icariin may provide with a new approach for sensitizing the radiotherapy in colorectal cancer.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

References

  1. Byeon, J. S., Yang, S. K., Kim, T. I., Kim, W. H., Lau, J. Y., Leung, W. K., et al. (2007). Colorectal neoplasm in asymptomatic Asians: A prospective multinational multicenter colonoscopy survey. Gastrointestinal Endoscopy, 65, 1015–1022.

    PubMed  Article  Google Scholar 

  2. Bosset, J. F., Calais, G., Mineur, L., Maingon, P., Radosevic-Jelic, L., Daban, A., et al. (2005). Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: Preliminary results—EORTC 22921. Journal of Clinical Oncology, 23, 5620–5627.

    CAS  PubMed  Article  Google Scholar 

  3. Andre, N., & Schmiegel, W. (2005). Chemoradiotherapy for colorectal cancer. Gut, 54, 1194–1202.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  4. Sauer, R., Becker, H., Hohenberger, W., Rodel, C., Wittekind, C., Fietkau, R., et al. (2004). Preoperative versus postoperative chemoradiotherapy for rectal cancer. New England Journal of Medicine, 351, 1731–1740.

    CAS  PubMed  Article  Google Scholar 

  5. Rodel, C., Martus, P., Papadoupolos, T., Fuzesi, L., Klimpfinger, M., Fietkau, R., et al. (2005). Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. Journal of Clinical Oncology, 23, 8688–8696.

    PubMed  Article  Google Scholar 

  6. Bonnen, M., Crane, C., Vauthey, J. N., Skibber, J., Delclos, M. E., Rodriguez-Bigas, M., et al. (2004). Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. International Journal of Radiation Oncology Biology Physics, 60, 1098–1105.

    Article  Google Scholar 

  7. Janjan, N. A., Crane, C., Feig, B. W., Cleary, K., Dubrow, R., Curley, S., et al. (2001). Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. American Journal of Clinical Oncology, 24, 107–112.

    CAS  PubMed  Article  Google Scholar 

  8. Sandur, S. K., Deorukhkar, A., Pandey, M. K., Pabon, A. M., Shentu, S., Guha, S., et al. (2009). Curcumin modulates the radiosensitivity of colorectal cancer cells by suppressing constitutive and inducible NF-kappaB activity. International Journal of Radiation Oncology Biology Physics, 75, 534–542.

    CAS  Article  Google Scholar 

  9. Chen, Y., Huang, J. H., Ning, Y., & Shen, Z. Y. (2011). Icariin and its pharmaceutical efficacy: research progress of molecular mechanism. Zhong Xi Yi Jie He Xue Bao, 9, 1179–1184.

    CAS  PubMed  Article  Google Scholar 

  10. Huang, X., Zhu, D., & Lou, Y. (2007). A novel anticancer agent, icaritin, induced cell growth inhibition, G1 arrest and mitochondrial transmembrane potential drop in human prostate carcinoma PC-3 cells. European Journal of Pharmacology, 564, 26–36.

    CAS  PubMed  Article  Google Scholar 

  11. Li, S., Dong, P., Wang, J., Zhang, J., Gu, J., Wu, X., et al. (2010). Icariin, a natural flavonol glycoside, induces apoptosis in human hepatoma SMMC-7721 cells via a ROS/JNK-dependent mitochondrial pathway. Cancer Letters, 298, 222–230.

    CAS  PubMed  Article  Google Scholar 

  12. Lin, C. C., Ng, L. T., Hsu, F. F., Shieh, D. E., & Chiang, L. C. (2004). Cytotoxic effects of Coptis chinensis and Epimedium sagittatum extracts and their major constituents (berberine, coptisine and icariin) on hepatoma and leukaemia cell growth. Clinical and Experimental Pharmacology and Physiology, 31, 65–69.

    CAS  PubMed  Article  Google Scholar 

  13. Wang, Y., Dong, H., Zhu, M., Ou, Y., Zhang, J., Luo, H., et al. (2010). Icariin exterts negative effects on human gastric cancer cell invasion and migration by vasodilator-stimulated phosphoprotein via Rac1 pathway. European Journal of Pharmacology, 635, 40–48.

    CAS  PubMed  Article  Google Scholar 

  14. Zhang, D. C., Liu, J. L., Ding, Y. B., Xia, J. G., & Chen, G. Y. (2013). Icariin potentiates the antitumor activity of gemcitabine in gallbladder cancer by suppressing NF-kappaB. Acta Pharmacologica Sinica, 34, 301–308.

    CAS  PubMed  Article  Google Scholar 

  15. Aggarwal, B. B. (2004). Nuclear factor-kappaB: the enemy within. Cancer Cell, 6, 203–208.

    CAS  PubMed  Article  Google Scholar 

  16. Kunnumakkara, A. B., Diagaradjane, P., Guha, S., Deorukhkar, A., Shentu, S., Aggarwal, B. B., et al. (2008). Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene products. Clinical Cancer Research, 14, 2128–2136.

    CAS  PubMed  Article  Google Scholar 

  17. Zeng, K. W., Fu, H., Liu, G. X., & Wang, X. M. (2010). Icariin attenuates lipopolysaccharide-induced microglial activation and resultant death of neurons by inhibiting TAK1/IKK/NF-kappaB and JNK/p38 MAPK pathways. International Immunopharmacology, 10, 668–678.

    CAS  PubMed  Article  Google Scholar 

  18. Xu, C. Q., Liu, B. J., Wu, J. F., Xu, Y. C., Duan, X. H., Cao, Y. X., et al. (2010). Icariin attenuates LPS-induced acute inflammatory responses: Involvement of PI3K/Akt and NF-kappaB signaling pathway. European Journal of Pharmacology, 642, 146–153.

    CAS  PubMed  Article  Google Scholar 

  19. Hsieh, T. P., Sheu, S. Y., Sun, J. S., & Chen, M. H. (2011). Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-kappaB regulated HIF-1alpha and PGE(2) synthesis. Phytomedicine, 18, 176–185.

    CAS  PubMed  Article  Google Scholar 

  20. Cheng, H., An, S. J., Zhang, X. C., Dong, S., Zhang, Y. F., Chen, Z. H., et al. (2011). In vitro sequence-dependent synergism between paclitaxel and gefitinib in human lung cancer cell lines. Cancer Chemotherapy and Pharmacology, 67, 637–646.

    CAS  PubMed  Article  Google Scholar 

  21. Takada, Y., Khuri, F. R., & Aggarwal, B. B. (2004). Protein farnesyltransferase inhibitor (SCH 66336) abolishes NF-kappaB activation induced by various carcinogens and inflammatory stimuli leading to suppression of NF-kappaB-regulated gene expression and up-regulation of apoptosis. Journal of Biological Chemistry, 279, 26287–26299.

    CAS  PubMed  Article  Google Scholar 

  22. Kuo, Y. C., Lin, W. C., Chiang, I. T., Chang, Y. F., Chen, C. W., Su, S. H., et al. (2012). Sorafenib sensitizes human colorectal carcinoma to radiation via suppression of NF-kappaB expression in vitro and in vivo. Biomedicine & Pharmacotherapy, 66, 12–20.

    CAS  Article  Google Scholar 

  23. Wu, J. M., Sheng, H., Saxena, R., Skill, N. J., Bhat-Nakshatri, P., Yu, M., et al. (2009). NF-kappaB inhibition in human hepatocellular carcinoma and its potential as adjunct to sorafenib based therapy. Cancer Letters, 278, 145–155.

    CAS  PubMed  Article  Google Scholar 

  24. You, M., Ku, P. T., Hrdlickova, R., & Bose, H. R., Jr. (1997). ch-IAP1, a member of the inhibitor-of-apoptosis protein family, is a mediator of the antiapoptotic activity of the v-Rel oncoprotein. Molecular and Cellular Biology, 17, 7328–7341.

    CAS  PubMed Central  PubMed  Google Scholar 

  25. Tamatani, M., Che, Y. H., Matsuzaki, H., Ogawa, S., Okado, H., Miyake, S., et al. (1999). Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. Journal of Biological Chemistry, 274, 8531–8538.

    CAS  PubMed  Article  Google Scholar 

  26. Catz, S. D., & Johnson, J. L. (2001). Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer. Oncogene, 20, 7342–7351.

    CAS  PubMed  Article  Google Scholar 

  27. Guttridge, D. C., Albanese, C., Reuther, J. Y., Pestell, R. G., & Baldwin, A. S., Jr. (1999). NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Molecular and Cellular Biology, 19, 5785–5799.

    CAS  PubMed Central  PubMed  Google Scholar 

  28. Voboril, R., & Weberova-Voborilova, J. (2006). Constitutive NF-kappaB activity in colorectal cancer cells: impact on radiation-induced NF-kappaB activity, radiosensitivity, and apoptosis. Neoplasma, 53, 518–523.

    CAS  PubMed  Google Scholar 

  29. Yu, L. L., Yu, H. G., Yu, J. P., Luo, H. S., Xu, X. M., & Li, J. H. (2004). Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human colorectal carcinoma tissue. World Journal of Gastroenterology, 10, 3255–3260.

    CAS  PubMed  Google Scholar 

  30. Kojima, M., Morisaki, T., Sasaki, N., Nakano, K., Mibu, R., Tanaka, M., et al. (2004). Increased nuclear factor-kB activation in human colorectal carcinoma and its correlation with tumor progression. Anticancer Research, 24, 675–681.

    CAS  PubMed  Google Scholar 

  31. Yu, H. G., Zhong, X., Yang, Y. N., Luo, H. S., Yu, J. P., Meier, J. J., et al. (2004). Increased expression of nuclear factor-kappaB/RelA is correlated with tumor angiogenesis in human colorectal cancer. International Journal of Colorectal Disease, 19, 18–22.

    CAS  PubMed  Article  Google Scholar 

  32. Hong, J., Zhang, Z., Lv, W., Zhang, M., Chen, C., Yang, S., et al. (2013). Icaritin synergistically enhances the radiosensitivity of 4T1 breast cancer cells. PLoS One, 8, e71347.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  33. Bongartz, T., Sutton, A. J., Sweeting, M. J., Buchan, I., Matteson, E. L., & Montori, V. (2006). Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: Systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA, 295, 2275–2285.

    CAS  PubMed  Article  Google Scholar 

  34. Mukogawa, T., Koyama, F., Tachibana, M., Takayanagi, A., Shimizu, N., Fujii, H., et al. (2003). Adenovirus-mediated gene transduction of truncated I kappa B alpha enhances radiosensitivity in human colon cancer cells. Cancer Science, 94, 745–750.

    Google Scholar 

  35. Wang, C. Y., Cusack, J. C., Jr., Liu, R., & Baldwin, A. S., Jr. (1999). Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB. Nature Medicine, 5, 412–417.

    Google Scholar 

  36. Yamagishi, N., Miyakoshi, J., & Takebe, H. (1997). Enhanced radiosensitivity by inhibition of nuclear factor kappa B activation in human malignant glioma cells. International Journal of Radiation Biology, 72, 157–162.

    Google Scholar 

  37. Kawamura, I., Morishita, R., Tsujimoto, S., Manda, T., Tomoi, M., Tomita, N., et al. (2001). Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice. Gene Therapy, 8, 905–912.

    Google Scholar 

  38. Russo, S. M., Tepper, J. E., Baldwin, A. S., Jr., Liu, R., Adams, J., Elliott, P., et al. (2001). Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB. IInternational Journal of Radiation Oncology Biology Physics, 50, 183–193.

    Google Scholar 

  39. Zviahintseva, T. V. (1998). The modelling of local radiation injuries to the skin. Fiziologicheskii Zhurnal, 44, 106–112.

    CAS  Google Scholar 

  40. Larici, A. R., del Ciello, A., Maggi, F., Santoro, S. I., Meduri, B., Valentini, V., et al. (2011). Lung abnormalities at multimodality imaging after radiation therapy for non-small cell lung cancer. Radiographics, 31, 771–789.

    PubMed  Article  Google Scholar 

  41. Hooning, M. J., Botma, A., Aleman, B. M., Baaijens, M. H., Bartelink, H., Klijn, J. G., et al. (2007). Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. Journal of the National Cancer Institute, 99, 365–375.

    PubMed  Article  Google Scholar 

Download references

Acknowledgments

This study was supported by Shandong Province Natural Science Foundation (No. Y2007C118) and Shandong Science and Technology Development Plan (No. 2011GGC03078).

Author information

Affiliations

Authors

Corresponding author

Correspondence to Tao Zhou.

Additional information

Yi Zhang and Yumei Wei contributed equally to this work.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Zhang, Y., Wei, Y., Zhu, Z. et al. Icariin Enhances Radiosensitivity of Colorectal Cancer Cells by Suppressing NF-κB Activity. Cell Biochem Biophys 69, 303–310 (2014). https://doi.org/10.1007/s12013-013-9799-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-013-9799-x

Keywords

  • Icariin
  • Radiation
  • NF-κB
  • Radiosensitivity
  • Colorectal cancer